Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | VS-4718 |
Trade Name | |
Synonyms | |
Drug Descriptions |
VS-4718 is a focal adhesion kinase (FAK) inhibitor, which prevents FAK autophosphorylation and activation of downstream YAP1 and Hippo pathway signaling, potentially resulting in decreased tumor cell proliferation, migration, and survival (PMID: 30773340). |
DrugClasses | FAK inhibitor 15 |
CAS Registry Number | 1061353-68-1 |
NCIT ID | C107238 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Cobimetinib + VS-4718 | Cobimetinib VS-4718 | 0 | 0 |
Gemcitabine + Nab-paclitaxel + VS-4718 | Gemcitabine Nab-paclitaxel VS-4718 | 0 | 1 |
RO5126766 + VS-4718 | RO5126766 VS-4718 | 0 | 0 |
Selumetinib + VS-4718 | Selumetinib VS-4718 | 0 | 0 |
Trametinib + VS-4718 | Trametinib VS-4718 | 0 | 0 |
VS-4718 | VS-4718 | 0 | 1 |